CompletedNCT04358419

Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate

Studying Aspergillosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Inger Lise Gade
Principal Investigator
Inger L Gade, MD PhD
Aalborg University Hospital
Intervention
Aspergillus specific proteins in exhaled breath condensate (EBC)(diagnostic_test)
Enrollment
101 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2023

Study locations (1)

Collaborators

Aarhus University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04358419 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis →

← Back to all trials